Why Chicken Soup For The Soul Entertainment Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Gainers

  • RiceBran Technologies (NASDAQ:RIBT) gained 43.1% to $1.33 in pre-market trading after gaining 3% on Tuesday.
  • Addex Therapeutics Ltd (NASDAQ:ADXN) jumped 35.4% to $1.25 in pre-market trading. Addex said it completed $5 million equity financing.
  • Millennium Group International Holdings Limited (NASDAQ:MGIH) shares climbed 25.8% to $4.04 in pre-market trading after dipping around 20% on Tuesday.
  • Ebang International Holdings Inc. (NASDAQ:EBON) gained 17.8% to $7.00 in pre-market trading after dropping 15% on Tuesday.
  • Chicken Soup for the Soul Entertainment, Inc. (NASDAQ:CSSE) gained 14.1% to $1.86 in pre-market trading. Chicken Soup For The Soul Entertainment’s Form4 filing showed CEO bought 1.8 million shares of common stock.
  • Virios Therapeutics, Inc. (NASDAQ:VIRI) climbed 12.2% to $0.3876 in pre-market trading after dropping 4% on Tuesday. The company recently posted a narrower-than-expected quarterly loss.
  • InflaRx N.V. (NASDAQ:IFRX) gained 10.8% to $4.18 in pre-market trading. InflaRx shares jumped 84% on Tuesday after the company announced it received FDA Emergency Use Authorization for Gohibic for the treatment of critically-ill COVID-19 patients.
  • Bird Global, Inc. (NYSE:BRDS) gained 9.3% to $0.2415 in pre-market trading after dropping around 15% on Tuesday. Bird Global recently announced the purchase of shares by management and directors.
  • Pyxis Oncology, Inc. (NASDAQ:PYXS) climbed 9.3% to $3.75 in pre-market trading after dropping more than 15% on Tuesday.
  • Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) surged 7.2% to $0.7451 in pre-market trading after dropping 9% on Tuesday.

Losers

  • Secoo Holding Limited (NASDAQ:SECO) fell 19.2% to $1.18 in pre-market trading after jumping 143% on Tuesday.
  • Nuvve Holding Corp. (NASDAQ:NVVE) fell 17.4% to $0.6490 in pre-market trading after gaining over 30% on Tuesday. Nuvve Holding recently posted better-than-expected quarterly sales.
  • First Wave BioPharma, Inc. (NASDAQ:FWBI) shares dropped 15.6% to $2.27 in pre-market trading after gaining 11% on Tuesday. First Wave BioPharma recently announced a $4.0 million private placement priced at-the-market under Nasdaq rules.
  • Sono Group N.V. (NASDAQ:SEV) shares fell 12.4% to $0.2980 in pre-market trading after dropping 6% on Tuesday.
  • Histogen Inc. (NASDAQ:HSTO) fell 11.7% to $1.06 in pre-market. Histogen reported exclusive intellectual property license agreement with Johns Hopkins University.
  • DLocal Limited (NASDAQ:DLO) fell 11.4% to $15.00 in pre-market trading after the company posted weaker-than-expected Q4 results.
  • The NFT Gaming Company, Inc. (NASDAQ:NFTG) fell 11.4% to $1.77 in pre-market trading. The NFT Gaming Company shares gained around 50% on Tuesday after the company provided a shareholder update on game launches, AI, Gaxos platform and other initiatives.
  • Bullfrog AI Holdings, Inc. (NASDAQ:BFRG) fell 10.7% to $5.36 in pre-market trading. Bullfrog AI shares jumped around 28% on Tuesday after the company announced a worldwide license agreement with Johns Hopkins University Applied Physics Laboratory for use of patented technology powering the company's bfLEAP platform..
  • Assure Holdings Corp. (NASDAQ:IONM) fell 9.7% to $3.34 in pre-market trading. Assure Hldgs, on Monday, posted a FY loss of $40.06 per share.
  • Oncternal Therapeutics, Inc. (NASDAQ:ONCT) shares fell 8.2% to $0.3125 in pre-market trading after dropping 57% on Tuesday. Oncternal Therapeutics said it will suspend Phase 3 and the Phase 1/2 studies of zilovertamab in combination with ibrutinib, citing the rapidly changing commercial landscape for Bruton's tyrosine kinase inhibitors (BTK inhibitors).

Now Read This: Top 4 Materials Stocks That Set To Fly In April


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: NewsPenny StocksPre-Market OutlookMarketsMoversTrading IdeasPremarket MoversTop Gainers